Oklo, Nano Nuclear Energy, NuScale Power, Centrus Energy, BWX Technologies, Lightbridge, and Karyopharm Therapeutics are the seven Nuclear stocks to watch today, according to MarketBeat’s stock screener tool. “Nuclear stocks” are shares of publicly traded companies involved in the nuclear energy sector—this includes operators of nuclear power plants, uranium miners and fuel producers, and manufacturers of reactors or related equipment. These stocks tend to be driven by government energy policies, uranium price cycles and the broader clean-energy transition, making them a specialized play for investors seeking exposure to emissions-free power and geopolitical factors. These companies had the highest dollar trading volume of any Nuclear stocks within the last several days.
Oklo (OKLO)
Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California.
Nano Nuclear Energy (NNE)
Read Our Latest Research Report on NNE
NuScale Power (SMR)
NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs.
Read Our Latest Research Report on SMR
Centrus Energy (LEU)
Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants.
Read Our Latest Research Report on LEU
BWX Technologies (BWXT)
BWX Technologies, Inc., together with its subsidiaries, manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The Government Operations segment designs and manufactures naval nuclear components, reactors, and nuclear fuel; fabrication activities; and supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers.
Read Our Latest Research Report on BWXT
Lightbridge (LTBR)
Read Our Latest Research Report on LTBR
Karyopharm Therapeutics (KPTI)
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1).
Read Our Latest Research Report on KPTI
Featured Articles
- MarketBeat’s Top Five Stocks to Own in October 2025
- Energy Transfer’s New Growth Engine Ignites Investor Interest
- AMD and OpenAI: A Partnership That Just Redrew the AI Map
- Will Firefly’s $855M SciTec Acquisition Ignite a Stock Re-Rating?
- Lithium Americas: Why This 31% Rally Is More Than Just a Headline
- Why Archer Aviation Stock Is Soaring—And What Comes Next